Private Capital Management LLC Moderna, Inc. Transaction History

Private Capital Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 18, 2024	SELL	$101.21 - $166.61 $94,428 - $155,447	-933 Reduced 27.04%	2,518 $299,000
Q1 2024 Apr 10, 2024	SELL	$85.37 - $115.44 $1,109 - $1,500	-13 Reduced 0.38%	3,451 $367,000
Q4 2023 Jan 09, 2024	BUY	$69.51 - $104.43 $1,598 - $2,401	23 Added 0.67%	3,464 $344,000
Q3 2023 Nov 13, 2023	BUY	$96.41 - $126.61 $29,212 - $38,362	303 Added 9.66%	3,441 $355,000
Q2 2023 Aug 03, 2023	BUY	$118.5 - $160.53 $124,069 - $168,074	1,047 Added 50.07%	3,138 $381,000
Q1 2023 May 11, 2023	BUY	$135.66 - $197.02 $406 - $591	3 Added 0.14%	2,091 $321,000
Q4 2022 Jan 30, 2023	SELL	$118.38 - $210.04 $113,289 - $201,008	-957 Reduced 31.43%	2,088 $375,000
Q3 2022 Nov 03, 2022	SELL	$118.07 - $194.18 $2,951 - $4,854	-25 Reduced 0.81%	3,045 $360,000
Q1 2022 Apr 20, 2022	BUY	$126.46 - $235.05 $255,575 - $475,036	2,021 Added 192.66%	3,070 $529,000
Q2 2021 Jul 22, 2021	BUY	$129.91 - $234.98 $136,275 - $246,494	1,049 New	1,049 $246,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Private Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Private Capital Management LLC with notifications on news.